The value of exports of commodity group 3006 "Pharmaceutical goods specified in Note 4 to this Chapter." from Israel totalled $ 23 million in 2023. Sales of commodity group 3006 from Israel decreased by 20% in value terms compared to 2022. exports of commodity group 3006 "Pharmaceutical goods specified in Note 4 to this Chapter." decreased by $ 6.22 million (cumulative exports of commodity group 3006 from Israel amounted $29 million in 2022)
Exports of commodity group 3006 "Pharmaceutical goods specified in Note 4 to this Chapter." amounted to 0.039% of total exports from Israel (cumulative merchandise exports from Israel totalled $ 59 billion in 2023). The share of commodity group 3006 in total exports from Israel decreased by 0.001 p.p. compared to 2022 (it was 0.041% in 2022 and cumulative exports from Israel were equal to $ 72 billion).
Exports of commodity group 3006 amounted to 1.31% of total sales of group "" from Israel in 2023 (the value of exports of commodity group from Israel amounted to $1.8 billion in 2023). The share of exports of commodity group 3006 in sales of commodity group from Israel increased by 0.374 p.p. compared to 2022 (it was 0.943% in 2022, and exports of commodity group from Israel were $3.17 billion).
Where does Israel export Pharmaceutical goods specified in Note 4 to this Chapter.?
Top export destinations of "Pharmaceutical goods specified in Note 4 to this Chapter." from Israel in 2023:
- USA with a share of 34% (8.25 million US$)
- France with a share of 15.7% (3.75 million US$)
- Netherlands with a share of 11% (2.63 million US$)
- Russia with a share of 5.65% (1.34 million US$)
- Germany with a share of 5.42% (1.28 million US$)
- Italy with a share of 4.02% (956 thousand US$)
- Canada with a share of 2.66% (634 thousand US$)
- China with a share of 2.48% (590 thousand US$)
- Korea with a share of 2.33% (554 thousand US$)
- Spain with a share of 1.53% (364 thousand US$)
Exports structure of 3006 - Pharmaceutical goods specified in Note 4 to this Chapter. - from Israel in 2023 represented by the following main commodity groups:
- 88% (21 million US$): 300640 - Dental cements & other dental fillings; bone reconstruction cements
- 5.94% (1.41 million US$): 300670 - Gel preparations designed to be used in human/veterinary medicine as a lubricant for parts of the body for surgical operations/physical examinations
- 2.12% (506 thousand US$): 300610 - Pharmaceutical goods; sterile surgical catgut, suture materials, tissue adhesives, laminaria, laminaria tents, absorbable surgical or dental haemostatics, and surgical or dental adhesion barriers
- 0.42% (100 thousand US$): 300650 - First-aid boxes & kits
- 0.084% (20 thousand US$): 300660 - Chemical contraceptive preparations based on hormones/other products of 29.37/spermicides
- 0.004% (1 thousand US$): 300630 - Opacifying preparations for X-ray examinations; diagnostic reagents designed to be administered to the patient
The value of imports of commodity group 3006 "Pharmaceutical goods specified in Note 4 to this Chapter." to Israel totalled $ 113 million in 2023. Sales of commodity group 3006 to Israel went up by 5.21% compared to 2022: imports of commodity group 3006 "Pharmaceutical goods specified in Note 4 to this Chapter." went up by $ 5.63 million (the value of imports of commodity group 3006 to Israel was equal to $108 million in 2022)
Imports of commodity group 3006 "Pharmaceutical goods specified in Note 4 to this Chapter." accounted for 0.136% of total import flow to Israel (in 2023, total imports to Israel amounted to $ 83 billion). The share of commodity group 3006 in total imports to Israel increased by 0.036 p.p. compared to 2022 (it was 0.1% in 2022 and cumulative imports to Israel were equal to $ 107 billion).
Imports of commodity group 3006 reached 3.44% of total imports of group "" to Israel in 2023 (imports of commodity group to Israel totalled $3.3 billion in 2023). The share of purchases of commodity group 3006 in total imports of commodity group to Israel increased by 0.451 p.p. compared to 2022 (it was 2.99% in 2022, and imports of commodity group to Israel accounted for $3.61 billion).
Where does Israel import Pharmaceutical goods specified in Note 4 to this Chapter. from?
Top trading partners (import of "Pharmaceutical goods specified in Note 4 to this Chapter.") of Israel in 2023:
- USA with a share of 20% (23 million US$)
- Germany with a share of 18% (20 million US$)
- Ireland with a share of 14.9% (17 million US$)
- Switzerland with a share of 9.02% (10.2 million US$)
- Japan with a share of 3.64% (4.15 million US$)
- France with a share of 3.58% (4.08 million US$)
- Austria with a share of 3.25% (3.7 million US$)
- Italy with a share of 2.73% (3.11 million US$)
- Hungary with a share of 2.41% (2.75 million US$)
- Denmark with a share of 2.02% (2.3 million US$)
Imports structure of 3006 - Pharmaceutical goods specified in Note 4 to this Chapter. - to Israel in 2023 represented by the following main commodity groups:
- 26% (30 million US$): 300610 - Pharmaceutical goods; sterile surgical catgut, suture materials, tissue adhesives, laminaria, laminaria tents, absorbable surgical or dental haemostatics, and surgical or dental adhesion barriers
- 19.9% (22 million US$): 300630 - Opacifying preparations for X-ray examinations; diagnostic reagents designed to be administered to the patient
- 14.7% (16.8 million US$): 300660 - Chemical contraceptive preparations based on hormones/other products of 29.37/spermicides
- 13.4% (15.2 million US$): 300640 - Dental cements & other dental fillings; bone reconstruction cements
- 1.75% (1.99 million US$): 300670 - Gel preparations designed to be used in human/veterinary medicine as a lubricant for parts of the body for surgical operations/physical examinations
- 1.48% (1.69 million US$): 300650 - First-aid boxes & kits